Umbilical Cord Mesenchymal Stem Cells Attenuate Podocyte Injury in Diabetic Nephropathy Rats by Inhibiting Angpltl4/Integrin <i>β</i>3 in the Glomerulus.

J Diabetes Res · 2025 · PMC12008490 · PMID 40256245

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Compared with placebo, a single intravenous infusion of allogeneic BMSCs showed a trend toward stabilizing or improving estimated glomerular filtration rate (eGFR) and measured glomerular filtration rate (mGFR) at week 12 after infusion [ 4 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Umbilical Cord Mesenchymal Stem Cells Attenuate Podocyte Injury in Diabetic Nephropathy Rats by Inhibiting Angpltl4/Integrin &lt;i&gt;β&lt;/i&gt;3 in the Glomerulus.

The sentences

Umbilical Cord Mesenchymal Stem Cells Attenuate Podocyte Injury in Diabetic Nephropathy Rats by Inhibiting Angpltl4/Integrin <i>β</i>3 in the Glomerulus.